background
effect
therapeut
treat
urgent
need
remdesivir
nucleotid
prodrug
vitro
vivo
efficaci
coronavirus
test
efficaci
remdesivir
treatment
rhesu
macaqu
model
infect
evalu
effect
remdesivir
treatment
diseas
outcom
use
recent
establish
rhesu
macaqu
model
infect
result
transient
lower
respiratori
tract
diseas
two
group
six
rhesu
macaqu
infect
treat
intraven
remdesivir
equal
volum
vehicl
solut
daili
clinic
virolog
histolog
paramet
assess
regularli
studi
necropsi
determin
treatment
efficaci
contrast
vehicletr
anim
anim
treat
remdesivir
show
sign
respiratori
diseas
reduc
pulmonari
infiltr
radiograph
viru
titer
bronchoalveolar
lavag
significantli
reduc
earli
first
treatment
administ
necropsi
day
inocul
lung
viral
load
remdesivirtr
anim
significantli
lower
clear
reduct
damag
lung
tissu
rhesu
macaqu
data
support
earli
remdesivir
treatment
initi
patient
prevent
progress
sever
pneumonia
effect
treatment
urgent
need
larg
number
investig
well
approv
repurpos
drug
suggest
util
treatment
preclin
data
anim
model
guid
focus
search
effect
treatment
human
rule
treatment
without
proven
efficaci
vivo
remdesivir
nucleotid
analog
prodrug
broad
antivir
activ
includ
coronavirus
current
investig
clinic
trial
worldwid
includ
china
us
europ
summar
anim
model
remdesivir
treatment
effect
merscov
sarscov
infect
vitro
remdesivir
inhibit
replic
moreov
vitro
experi
shown
mutat
confer
resist
remdesivir
easili
emerg
coronavirus
investig
efficaci
remdesivir
treatment
recent
establish
rhesu
macaqu
model
infect
model
infect
rhesu
macaqu
develop
mild
moder
transient
respiratori
diseas
pulmonari
infiltr
visibl
radiograph
shed
pattern
similar
observ
patient
therapeut
treatment
rhesu
macaqu
remdesivir
shortli
peak
viru
replic
result
signific
clinic
improv
reduct
pulmonari
infiltr
reduct
pulmonari
patholog
anim
experi
approv
institut
anim
care
use
committe
rocki
mountain
laboratori
nih
carri
certifi
staff
associ
assess
accredit
laboratori
anim
care
aaalac
intern
accredit
facil
accord
institut
guidelin
anim
use
follow
guidelin
basic
principl
nih
guid
care
use
laboratori
anim
anim
welfar
act
unit
state
depart
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
agricultur
unit
state
public
health
servic
polici
human
care
use
laboratori
anim
rhesu
macaqu
hous
adjac
individu
primat
cage
allow
social
interact
climatecontrol
room
fix
lightdark
cycl
dark
anim
monitor
least
twice
daili
throughout
experi
commerci
monkey
chow
treat
fruit
provid
twice
daili
train
personnel
water
avail
ad
libitum
environment
enrich
consist
varieti
human
interact
manipulanda
commerci
toy
video
music
institut
biosafeti
committe
ibc
approv
work
infecti
strain
condit
sampl
inactiv
perform
accord
ibcapprov
standard
oper
procedur
remov
specimen
high
contain
evalu
effect
remdesivir
treatment
diseas
outcom
use
recent
establish
rhesu
macaqu
model
infect
result
transient
lower
respiratori
tract
diseas
twelv
anim
randomli
assign
two
group
inocul
describ
previous
total
dose
strain
via
intranas
oral
ocular
intratrach
rout
efficaci
therapeut
remdesivir
treatment
test
two
group
six
adult
rhesu
macaqu
male
femal
due
acut
natur
model
rhesu
macaqu
therapeut
treatment
initi
hour
inocul
continu
daili
day
post
inocul
dpi
one
group
rhesu
macaqu
treat
load
dose
remdesivir
follow
daili
mainten
dose
mgkg
group
six
anim
serv
infect
control
administ
equal
dose
volum
ie
mlkg
load
dose
mlkg
thereaft
vehicl
solut
water
hydrochlor
acid
accord
treatment
schedul
dose
scheme
rhesu
macaqu
mimic
daili
dose
test
clinic
studi
patient
result
similar
system
drug
exposur
treatment
deliv
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
intraven
bolu
inject
total
dose
deliv
approxim
minut
administ
alternatingli
left
right
cephal
saphen
vein
anim
observ
twice
daili
clinic
sign
diseas
use
standard
score
sheet
describ
previous
person
blind
group
assign
anim
assess
anim
throughout
studi
predetermin
endpoint
experi
dpi
nose
throat
rectal
swab
collect
daili
treatment
administr
clinic
exam
perform
dpi
anaesthet
anim
exam
day
clinic
paramet
bodyweight
temperatur
puls
oximetri
blood
pressur
respir
rate
collect
well
dorsalventr
later
chest
radiograph
radiograph
analyz
clinic
veterinarian
blind
group
assign
anim
dpi
bronchoalveolar
lavag
bal
perform
use
steril
salin
euthanasia
dpi
necropsi
perform
percentag
gross
lung
lesion
score
boardcertifi
veterinari
pathologist
blind
group
assign
anim
sampl
follow
tissu
collect
cervic
lymph
node
conjunctiva
nasal
mucosa
oropharynx
tonsil
trachea
lung
lobe
mediastin
lymph
node
right
left
bronchu
heart
liver
spleen
kidney
stomach
duodenum
jejunum
ileum
cecum
colon
urinari
bladder
histopatholog
analysi
tissu
slide
perform
boardcertifi
veterinari
pathologist
blind
group
assign
anim
isol
vero
passag
kindli
provid
cdc
propag
vero
cell
dmem
sigma
supplement
fetal
bovin
serum
gibco
mm
lglutamin
gibco
uml
penicillin
streptomycin
gibco
viru
isol
medium
viru
stock
use
ident
initi
deposit
genbank
sequenc
contamin
detect
cell
maintain
dmem
supplement
fetal
calf
serum
mm
lglutamin
uml
penicillin
streptomycin
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
remdesivir
rdv
manufactur
gilead
scienc
depart
process
chemistri
alberta
canada
good
manufactur
practic
gmp
condit
batch
number
solubil
water
match
vehicl
solut
provid
nih
tributylamin
purchas
millipor
sigma
lcm
grade
water
aceton
methanol
isopropanol
acet
acid
purchas
fisher
scientif
synthet
standard
molecular
analysi
provid
gilead
scienc
inc
serum
clear
lung
homogen
gammairradi
mrad
inactiv
infecti
viru
potenti
present
sampl
prior
analysi
sampl
prepar
small
molecul
analysi
dilut
aliquot
either
serum
clarifi
lung
homogen
aceton
methanol
water
vv
ice
sampl
incub
room
temperatur
min
centrifug
xg
minut
clarifi
supernat
recov
taken
dryness
concentr
thermo
fisher
sampl
resuspend
methanol
water
vv
centrifug
supernat
taken
sampl
vial
lcm
analysi
sampl
separ
use
ionpair
liquid
chromatographi
strategi
sciex
ac
system
sampl
inject
onto
water
atlanti
column
mm
x
mm
elut
use
binari
gradient
mm
tributylamin
mm
acet
acid
isopropanol
methanol
water
vv
isopropanol
minut
analyt
measur
use
sciex
mass
spectromet
neg
mode
multipl
reaction
monitor
perform
use
two
signal
pair
analyt
signal
fidel
confirm
collect
trigger
product
ion
spectra
compar
back
spectra
synthet
pure
standard
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
analyt
quantifi
calibr
curv
respect
synthet
standard
prepar
target
matrix
ie
serum
clear
lung
homogen
process
manner
experiment
sampl
limit
quantif
loq
approxim
signal
nois
loq
measur
molecul
matrix
nm
lung
homogen
serum
nm
lung
homogen
serum
nm
serum
instabl
triphosphoryl
nucleotid
metabolit
lung
homogen
tissu
lysi
prevent
detect
metabolit
lung
tissu
rna
extract
swab
bal
use
qiaamp
viral
rna
kit
qiagen
accord
manufactur
instruct
tissu
mg
homogen
rlt
buffer
rna
extract
use
rneasi
kit
qiagen
accord
manufactur
instruct
detect
viral
rna
rna
use
onestep
realtim
rtpcr
e
assay
use
rotorgen
probe
kit
qiagen
accord
instruct
manufactur
run
standard
dilut
rna
standard
count
droplet
digit
pcr
run
parallel
calcul
copi
number
sampl
viru
titrat
perform
endpoint
titrat
vero
cell
tissu
homogen
dmem
use
tissuelys
qiagen
cell
inocul
serial
dilut
swab
bal
sampl
viru
isol
perform
lung
tissu
homogen
tissu
dmem
inocul
vero
cell
well
plate
clear
homogen
dilut
thereof
one
hour
inocul
cell
inoculum
remov
replac
viru
titrat
viru
isol
medium
six
day
inocul
cpe
score
calcul
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
histopatholog
immunohistochemistri
perform
rhesu
macaqu
tissu
fixat
minimum
day
neutralbuff
formalin
embed
paraffin
tissu
section
stain
hematoxylin
eosin
detect
antigen
immunohistochemistri
perform
use
custommad
rabbit
antiserum
n
dilut
stain
slide
analyz
boardcertifi
veterinari
pathologist
viral
rna
extract
describ
cdna
prepar
accord
bries
raw
fastq
read
trim
illumina
adapt
sequenc
use
cutadapt
version
trim
filter
qualiti
use
fastxtoolkit
hannon
lab
remain
read
map
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
paramet
local
nomix
x
pcr
duplic
remov
use
picard
markdupl
broad
institut
variant
call
use
gatk
haplotypecal
version
parameterploidi
variant
filter
qual
dp
use
bcftool
statist
analys
perform
use
graphpad
prism
softwar
version
data
includ
manuscript
deposit
figshar
http
two
group
six
rhesu
macaqu
inocul
strain
twelv
hour
post
inocul
one
group
administ
intraven
remdesivir
group
treat
equal
volum
vehicl
solut
treatment
continu
first
treatment
everi
hr
thereaft
dose
mgkg
remdesivir
equal
volum
vehicl
solut
serum
concentr
remdesivir
determin
serum
collect
hr
initi
treatment
hr
subsequ
treatment
administ
immedi
next
dose
treatment
administ
detect
level
remdesivir
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
concentr
metabolit
determin
lung
tissu
collect
lung
lobe
dpi
hr
last
remdesivir
treatment
administ
readili
detect
remdesivirtr
anim
gener
distribut
amongst
six
lobe
lung
fig
detect
lung
tissu
pharmacolog
activ
metabolit
remdesivir
triphosph
lung
homogen
sampl
spike
triphosph
metabolit
demonstr
rapid
decay
metabolit
matrix
data
shown
level
taken
surrog
tissu
load
suggest
current
dose
strategi
deliv
drug
metabolit
site
replic
infect
anim
inocul
anim
assign
daili
clinic
score
base
preestablish
score
sheet
blind
fashion
twelv
hour
first
remdesivir
treatment
clinic
score
remdesivirtr
anim
significantli
lower
control
anim
receiv
vehicl
solut
differ
clinic
score
maintain
throughout
studi
fig
one
six
remdesivirtr
anim
show
mild
dyspnea
wherea
tachypnea
dyspnea
observ
vehicletr
control
tabl
radiograph
pulmonari
infiltr
one
hallmark
human
radiograph
taken
dpi
show
significantli
less
lung
lobe
involv
less
sever
pulmonari
infiltr
anim
treat
remdesivir
compar
receiv
vehicl
fig
c
dpi
bal
perform
indic
viru
replic
lower
respiratori
tract
although
viral
load
bal
reduc
remdesivirtr
anim
differ
statist
signific
fig
howev
hour
first
remdesivir
treatment
administ
infecti
viru
titer
bal
lower
remdesivirtr
anim
control
dpi
infecti
viru
could
longer
detect
bal
remdesivirtr
anim
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
wherea
viru
still
detect
bal
four
six
control
anim
fig
despit
reduct
viru
replic
lower
respiratori
tract
neither
viral
load
infecti
viru
titer
reduc
nose
throat
rectal
swab
collect
remdesivirtr
anim
except
signific
differ
viru
titer
throat
swab
collect
dpi
viral
load
throat
swab
collect
dpi
fig
anim
euthan
dpi
tissu
sampl
collect
lung
lobe
compar
viru
replic
remdesivirtr
vehicletr
control
anim
lung
lobe
sampl
collect
remdesivirtr
anim
viral
rna
could
detect
wherea
case
lung
lobe
collect
control
anim
gener
comparison
across
individu
lung
lobe
two
group
show
lower
geometr
mean
viral
rna
remdesivirtr
group
fig
taken
togeth
viral
load
significantli
lower
lung
remdesivirtr
anim
vehicletr
control
fig
viru
could
isol
lung
lobe
five
six
vehicletr
control
anim
none
lung
tissu
collect
remdesivirtr
anim
posit
viru
isol
although
fewer
tissu
posit
respiratori
tract
posit
qrtpcr
remdesivirtr
anim
differ
statist
signific
fig
necropsi
dpi
lung
assess
grossli
presenc
lesion
gross
lung
lesion
observ
one
six
remdesivirtr
anim
contrast
six
vehicl
control
visibl
lesion
result
statist
significantli
differ
area
lung
affect
lesion
fig
b
fig
b
differ
also
evid
calcul
lung
weight
bodyweight
ratio
indic
pneumonia
statist
significantli
lower
ratio
observ
remdesivirtr
compar
vehicletr
anim
fig
histolog
clear
effect
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
remdesivir
treatment
lung
lesion
fewer
less
sever
lesion
remdesivir
anim
vehicletr
control
histolog
lung
lesion
absent
three
six
remdesivirtr
anim
three
remain
anim
develop
minim
pulmonari
patholog
lesion
anim
character
wide
separ
minim
interstiti
pneumonia
frequent
locat
subpleur
space
fig
e
five
six
vehicletr
anim
develop
multifoc
mild
moder
interstiti
pneumonia
fig
f
viral
antigen
detect
anim
regardless
treatment
fig
h
deep
sequenc
success
sampl
remdesivirtr
anim
vehicl
control
known
mutat
rna
depend
rna
polymeras
confer
resist
remdesivir
coronavirus
detect
sampl
test
tabl
remdesivir
first
antivir
treatment
proven
efficaci
anim
model
remdesivir
treatment
rhesu
macaqu
infect
highli
effect
reduc
clinic
diseas
damag
lung
remdesivir
dose
use
rhesu
macaqu
equival
use
human
howev
due
acut
natur
diseas
rhesu
macaqu
hard
directli
translat
time
treatment
use
correspond
diseas
stage
human
studi
treatment
administ
close
peak
viru
replic
lung
indic
viral
load
bronchoalveolar
lavag
first
effect
treatment
clinic
sign
viru
replic
observ
within
hour
efficaci
directact
antivir
acut
viral
respiratori
tract
infect
typic
decreas
delay
treatment
init
thu
remdesivir
treatment
patient
initi
earli
possibl
achiev
maximum
treatment
effect
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
author
affili
gilead
scienc
employe
compani
compani
stock
author
affili
nih
conflict
interest
report
ventrodors
later
radiograph
score
presenc
pulmonari
infiltr
clinic
veterinarian
accord
standard
score
system
normal
mild
interstiti
pulmonari
infiltr
moder
pulmonari
infiltr
perhap
partial
cardiac
border
effac
small
area
pulmonari
consolid
sever
interstiti
infiltr
larg
area
pulmonari
consolid
alveolar
pattern
air
bronchogram
individu
lobe
score
score
per
anim
per
day
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
total
display
panel
c
show
ventrodors
radiograph
collect
anim
taken
dpi
area
pulmonari
infiltr
mark
circl
statist
analysi
perform
use
anova
sidak
multipl
comparison
test
p
p
p
panel
b
show
infecti
viru
titer
bal
collect
rhesu
macaqu
infect
treat
remdesivir
red
circl
vehicl
solut
black
squar
statist
analysi
perform
use
anova
sidak
multipl
comparison
test
p
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
lung
lobe
score
presenc
histolog
lung
lesion
predetermin
scale
valu
combin
per
anim
graph
data
panel
analyz
use
anova
sidak
multipl
comparison
test
data
panel
bd
analyz
use
unpair
test
p
p
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
also
made
avail
use
licens
certifi
peer
review
authorfund
articl
us
govern
work
subject
copyright
usc
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
